26 April 2024
Benchmark Holdings
plc
("Benchmark" or "the
Company")
Notice of Q2 and Interim
Results
Webcast for analysts and
institutional investors
Equity Development webcast
for retail investors
Benchmark Holdings plc (AIM: BMK,
Euronext Growth Oslo: BMK), the aquaculture biotechnology business,
will announce its Q2 and interim results, for the three and six
month periods ended 31 March 2024, on Wednesday, 22 May
2024.
Presentation for analysts and
institutional investors at 8.00 UK (9.00 CET)
Trond Williksen, Chief Executive
Officer and Septima Maguire, Chief Financial Officer will host a
presentation for analysts and institutional investors on the day at
08.00 UK time (9.00 CET).
The presentation will be held in
person at Haakon Vlls Gate 2, Oslo, Norway. To register your
interest, please contact benchmark@mhpgroup.com
A live webcast of the presentation
will be available for analysts and investors to join remotely at
the following link:
https://channel.royalcast.com/landingpage/hegnarmedia/20240522_1/
Equity Development webcast for
retail investors at 12:30pm UK time
Trond Williksen, Chief Executive
Officer and Septima Maguire, Chief Financial Officer will host a
second webcast for retail investors and wealth managers at 12.30pm
UK time. The webcast is open to all existing and potential
shareholders.
To register please visit:
https://www.equitydevelopment.co.uk/news-and-events/benchmark-investor-presentation-22may2024
For further information, please
contact:
|
|
Benchmark Holdings plc
|
benchmark@mhpgroup.com
|
Trond Williksen, CEO
|
|
Septima Maguire, CFO
|
|
Ivonne Cantu, Investor
Relations
|
|
|
|
|
|
Deutsche Numis (Broker and
NOMAD)
|
Tel:
020 7260 1000
|
Freddie Barnfield, Duncan Monteith,
Sher Shah
|
|
|
|
MHP
|
Tel:
07884 494112
|
Katie Hunt, Reg Hoare
|
benchmark@mhpgroup.com
|
Equity Development
Hannah Crowe
|
Tel:
020 7065 2692
|
|
|
About Benchmark
Benchmark is a leading aquaculture
biotechnology company. Benchmark's mission is to enable aquaculture
producers to improve their sustainability and
profitability.
We bring together biology and
technology to develop innovative products and solutions which
improve yield, quality and animal health and welfare for our
customers. We do this by improving the genetic make-up, health and
nutrition of their stock - from broodstock and hatchery through to
nursery and grow out.
Benchmark has a broad portfolio of
products and solutions, including salmon eggs, live feed (Artemia),
specialist diets and probiotics and sea lice treatments. Find out
more at www.benchmarkplc.com.